Acta Chir Orthop Traumatol Cech. 2026; 93(3):170-177 | DOI: 10.55095/achot2026/018

Bacteriophage Therapy in Orthopaedics and Trauma:

RADEK BARTOŠKA1, 5, VLADISLAV BARTÁK2, 5, JIŘÍ GALLO3, 5, DAVID MUSIL4, 5
1 Ortope dicko-traumatologická klinika 3. lékařské fakulty Univerzity Karlovy a Fakultní nemocnice Královské Vinohrady, Praha
2 I. ortopedická klinika 1. lékařské fakulty Univerzity Karlovy a Fakultní nemocnice Motol a Homolka, Praha
3 Ortopedická klinika Lékařské fakulty Univerzity Palackého a Fakultní nemocnice Olomouc
4 Ortopedické oddělení Nemocnice České Budějovice
5 O dborná pracovní skupina pro infekce muskuloskeletálního aparátu při ČSOT

Keywords: bacteriophage therapy, FRI, PJI, biofilm-associated infection,antimicrobial resistance, orthopedic surgery, implant-associated infection, local treatment.

Received: April 1, 2026; Revised: April 1, 2026; Accepted: April 16, 2026; Published: July 1, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
BARTOŠKA R, BARTÁK V, GALLO J, MUSIL D. Bacteriophage Therapy in Orthopaedics and Trauma:. Acta Chir Orthop Traumatol Cech. 2026;93(3):170-177. doi: 10.55095/achot2026/018.
Download citation

References

  1. Alt V, Gessner A, Merabishvili M, Hitzenbichler F, Mannala GK, Peterhoff D, Walter N, Pirnay JP, Hiergeist A, Rupp M. Case report: Local bacteriophage therapy for fracture-related infection with polymicrobial multi-resistant bacteria: Hydrogel application and postoperative phage analysis through metagenomic sequencing. Front Med (Lausanne). 2024;11:1428432. Go to original source...
  2. Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629-655. Go to original source...
  3. Arens DK, Rodriguez AR, Huh EY, Wang HH, Burdette AJ, Hwang YY. Enhancing orthopedic infection control: Carbon scaffold-mediated phage therapy for methicillin-resistant Staphylococcus aureus in fracture-related infections. Biomed Phys Eng Express. 2025;11:017005. Go to original source...
  4. Barr JJ, Auro R, Furlan M, Whiteson KL, Erb ML, Pogliano J, Stotland A, Wolkowicz R, Cutting AS, Doran KS, Salamon P, Youle M, Rohwer F. Bacteriophage adhering to mucus provide a non-host-derived immunity. Proc Natl Acad Sci U S A. 2013;110:10771-10776. Go to original source...
  5. Brüssow H, Canchaya C, Hardt WD. Phages and the evolution of bacterial pathogens: From genomic rearrangements to lysogenic conversion. Microbiol Mol Biol Rev. 2004;68:560-602. Go to original source...
  6. Cano EJ, Caflisch KM, Bollyky PL, Van Belleghem JD, Patel R, Fackler J, Brownstein MJ, Horne B, Biswas B, Henry M, Malagon F, Lewallen DG, Suh GA. Phage therapy for limb-threatening prosthetic knee Klebsiella pneumoniae infection: Case report and in vitro characterization of anti-biofilm activity. Clin Infect Dis. 2021;73:e144-e151. Go to original source...
  7. Chanishvili N. Phage therapy -history from Twort and d'Herelle through Soviet experience to current approaches. Adv Virus Res. 2012;83:3-40. Go to original source...
  8. Chen B, Benavente LP, Chittò M, Wychowaniec JK, Post V, D'Este M, Constant C, Zeiter S, Feng W, Moreno MG, Trampuz A, Wagemans J, Onsea J, Richards RG, Lavigne R, Moriarty TF, Metsemakers WJ. Alginate microbeads and hydrogels delivering meropenem and bacteriophages to treat Pseudomonas aeruginosa fracture-related infections. J Control Release. 2023;364:159-173. Go to original source...
  9. Chen B, Ponce Benavente L, Chittò M, Post V, Constant C, Zeiter S, Nylund P, D'Este M, González Moreno M, Trampuz A, Wagemans J, Lavigne R, Onsea J, Richards RG, Metsemakers WJ, Moriarty TF. Combination of bacteriophages and vancomycin in a co-delivery hydrogel for localized treatment of fracture-related infections. NPJ Biofilms Microbiomes. 2024;10:77. Go to original source...
  10. Clarke AL, De Soir S, Jones JD. The safety and efficacy of phage therapy for bone and joint infections: A systematic review. Antibiotics (Basel). 2020;9:795. Go to original source...
  11. Comeau AM, Tétart F, Trojet SN, Prère MF, Krisch HM. Phage-antibiotic synergy (PAS): Beta-lactam and quinolone antibiotics stimulate virulent phage growth. PLoS One. 2007;2:e799. Go to original source...
  12. Eskenazi A, Lood C, Wubbolts J, Hites M, Balarjishvili N, Leshkasheli L, Askilashvili L, Kvachadze L, van Noort V, Wagemans J, Jayankura M, Chanishvili N, de Boer M, Nibbering P, Kutateladze M, Lavigne R, Merabishvili M, Pirnay JP. Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae. Nat Commun. 2022;13:302. Go to original source...
  13. Ferriol-González C, Domingo-Calap P. Phages for biofilm removal. Antibiotics (Basel). 2020;9:268. Go to original source...
  14. Ferry T, Onsea J, Roussel-Gaillard T, Batailler C, Moriarty TF, Metsemakers WJ. Bacteriophage therapy in musculoskeletal infections: from basic science to clinical application. EFORT Open rev. 2024;9:339-348. Go to original source...
  15. Fischetti VA. Bacteriophage endolysins: A novel anti-infective to control Gram-positive pathogens. Int J Med Microbiol. 2010;300:357-362. Go to original source...
  16. Górski A, Międzybrodzki R, Węgrzyn G, Jończyk-Matysiak E, Borysowski J, Weber-Dąbrowska B. Phage therapy:Current status and perspectives. Med Res Rev. 2020;40:459-463. Go to original source...
  17. Kaur S, Harjai K, Chhibber S. Methicillin-resistant Staphylococcus aureus phage plaque size enhancement using sublethal concentrations of antibiotics. Appl Environ Microbiol. 2012;78:8227-8233. Go to original source...
  18. Liu Z, Tan X, Xiong M, Lu S, Yang Y, Zhu H, Zhang J, Luo X, Zhou C, Wei S, Zhou N, Liu X, Bai C, Pan Y, Ma Y. Efficacy of precisely tailored phage cocktails targeting carbapenem-resistant Acinetobacter baumannii reveals evolutionary trade-offs: A proof-of-concept study. EBioMedicine. 2025;120:105942. Go to original source...
  19. Metsemakers WJ, Morgenstern M, McNally MA, Moriarty TF, McFadyen I, Scarborough M, Athanasou NA, Ochsner PE, Kuehl R, Raschke M, Borens O, Xie Z, Velkes S, Hungerer S, Kates SL, Zalavras C, Giannoudis PV, Richards RG, Verhofstad MHJ. Fracture-related infection: a consensus on definition from an international expert group. Injury. 2018;49:505-510. Go to original source...
  20. Migliorini F, Schäfer L, Vaishya R, Eschweiler J, Oliva F, Driessen A, Pipino G, Maffulli N. Bacteriophages in hip and knee periprosthetic joint infections: a promising tool in the era of antibiotic resistance. Med Sci (Basel). 2025;14:9. Go to original source...
  21. Munteanu DI, Dunn J, Apjok G, Kintses B, Griselain J, Steurs G, Cochez C, Djebara S, Merabishvili M, Pirnay JP, Štilec V, Peterka M, Simpson EA, Downie S, MacInnes A, Nicol G, Clift B, Jones JD. Phage therapy for orthopaedic infections: The first three cases from the United Kingdom. Antibiotics (Basel). 2025;14:114. Go to original source...
  22. Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, Rao N, Hanssen A, Wilson WR. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56:e1-e25. Go to original source...
  23. Pires DP, Oliveira H, Melo LD, Sillankorva S, Azeredo J. Bacteriophage-encoded depolymerases: Their diversity and biotechnological applications. Appl Microbiol Biotechnol. 2016;100:2141-2151. Go to original source...
  24. Pirnay JP, Verbeken G, Ceyssens PJ, Huys I, De Vos D, Ameloot C, Fauconnier A. The magistral phage. Viruses. 2018;10:64. Go to original source... Go to PubMed...
  25. Rupp M, Ferry T, Khan Mirzaei M, Alt V, Deng L, Walter N. Bacteriophages for the treatment of musculoskeletal infections-An overview of clinical use, open questions, and legal framework. Orthopadie (Heidelb). 2025;54:904-912. Go to original source...
  26. Schweser K, Bozynski CC, Stoker AM, Gull T, Duren D, Cook JL. Bacteriophage therapy for acute fracture-related infections: An effective treatment when compared with antibiotics in a canine model. J Orthop Trauma. 2025;39:144-152. Go to original source...
  27. Straka M, Hubenakova Z, Lichvarikova A, Janosikova L, Markuskova B, Minich A, Liptakova A, Drahovska H, Slobodnikova L. Susceptibility of Staphylococcus aureus strains to commercial therapeutic phage preparations. Bratisl Lek Listy. 2022;123:724-729. Go to original source...